Human iPS RT-PCR RT-PCR Primer Set, Complete set of RT-PCR primers for 43 marker genes for iPSC detection.
S
tem cells have two distinguishing features: features: 1. They have the ability to grow indenitely in an undifferentiated state and 2. They maintain pluripotency, the potential to develop into any type of cell. Embryonic stem (ES) cells were rst isolated from inner cell mass of mammalian mammalian blastocysts. blastocysts. Induced pluripotent stem (iPS) cells are cells reprogrammed from adult cells. iPS cells resemble ES cells in morphology, proliferation, gene expression, and teratoma formation. formation. They all form tightly packed and at colonies of cells, characterized by large nuclei and scant cytoplasm [1]. Both types of stem cells can spontaneously differentiate or undergo induced or directed cell fate commitment. One simple method for analyzing the differentiation status of iPS or ES cells is to use RT-PCR. RT-PCR. As demonstrated demonstrate d by Takahashi et al. in their landmark article in Cell , RT-PCR analysis of a set of ES cell markers should provide clear identication of stem cell colonies. In addition, RT-PCR RT-PCR was performed performed to demonstrate the presence of all three germ layers, or specic differentiation pathways.
Description The aim of Allele’s iPS RT-PCR RT-PCR primer sets is to provide researches with an efcient tools to initiate work in the iPS or ES eld. Primers are suitable for analyzing the reprogramming or differentiation stage of iPS or ES cells. Instead of ordering individual oligos, complete sets of primers, as precisely dened and tested in Takahashi Takahashi et al. 2007 [1], are conveniently and sufciently provided for 50 reactions for each gene. Each batch of primers is vigorously tested for oligo integrity. integrity.
Protocols RT-PCR: 1. Purify
total RNA from cells using RNA purication purication
kit or reagent. 2.
Use 1 µg total RNA and 1 µl of 20 µM dT(20) in reserve transcription reaction with a high quality reverse transcriptase. Follow manufacturer’s manufacturer’s instructions. PCR protocol (using Allele-in-One Mix):
Box 2 | Recommended PCR Setup Component
Volume
Final Conc.
25µL
NA
Template DNA (1ng/µl)
1µl
20 pg/µl
Upstream primer (20
1 µl
0.6 µM
1 µl
0.6 µM
21 µl
NA
Allele-in One MasterMix
PCR
µM)
Downstream genespecic primer (20 µM) Nuclease-free water
The following procedure is suggested as a starting point when using Taq polymerase:
Box 3 | Recommended PCR Setup
Features ♦ Pre-tested and complete set of RT-PCR RT-PCR primers for: 25 stem cell marker genes and 18 germ layer specic neuron or cardiomyocyte differentiation marker genes with housekeeping control. ♦ All sequences are identical to those as published by Takahashi et al. in their 2007 publication in Cell that Cell that demonstrated human iPS for the rst time.
Component
Volume
Final Conc.
Taq DNA Polymerase
5 units
NA
Template DNA (1ng/µl)
1µl
20 pg/µl
Upstream primer (20
1 µl
0.6 µM
µM)
♦ All oligos were produced in-house at Allele Biotech with quality control provided at uniform concentrations for easy reaction setup.
Downstream genespecic primer (20 µM)
1 µl
0.6 µM
♦ Additional controls are included
10 X PCR buffer
5 µl
1X
10 mM dNTP mix
1 µl
Box 1 | Product Info Human iPS RT-PCR Primer Set CAT# ABP-SC-iPShRES
Nuclease-free water
0.2 mM
add to nal volume of 50 µl
Contents dT(20) primer for reverse transcription (50 μl at 20 μM) 45 pairs of RT-PCR primers Primers are provided for 25 ES marker genes, 8 g erm erm layer markers, 6 neuron markers, 4 cardiomyocute markers, 2 control house-keeping genes, as in [1]. Information is provided in Table 1-2 on the next page.
Perform 30 – 40 cycles of PCR amplication (2-step) as follows: Denature 94°C for 30 sec Anneal 58°C for 30 sec Anneal and extend 72°C for 1min
Allele Biotech-Introducing Cost Effectiveness to Research
References Takahashi, K., et al., Induction of pluripotent stem cells from adult human broblast by dened factors. Cell, 2007. 131(5): p. 861-72.
1.
FTherapeutic Use.
or Research Use Only. Not for Diagnostic or
Purchase does not include or carry any right to resell or transfer this product either as a stand-alone product or as a component of another product. Any use of this product other than the permitted use without the express written authorization of Allele Biotech is strictly prohibited
Table 1 | Human iPS RT-PCR Primers Symbol
Accession
Primers Sequence
Undifferentiated ES cell
OCT3/4 (POU5F1)
NM_002701.4
hOCT3/4-S1165:GACAGGGGGAGGGGAGGAGCTAGG
Undifferentiated ES cell
SOX2
NM_003106.2
Undifferentiated ES cell
NANOG
Undifferentiated ES cell
GDF3
Undifferentiated ES cell
ZFP42 (REX1)
NM_174900.3
Undifferentiated ES cell
FGF4
NM_002007.2
Undifferentiated ES cell
ESG1 (DPPA5)
NM_00102529 0.1
hpH34-S40:ATATCCCGCCGTGGGTGAAAGTTC
Undifferentiated ES cell
DPPA4
NM_018189.3
hECAT15-1-S532:GGAGCCGCCTGCCCTGGAAAATTC
Undifferentiated ES cell
DPPA2
Undifferentiated ES cell
TERT
Undifferentiated ES cell
KLF4
Undifferentiated ES cell
c-Myc
Undifferentiated ES cell
DNMT3B
Undifferentiated ES cell
GABRB3
Undifferentiated ES cell
TDGF1
Undifferentiated ES cell
GAL
Undifferentiated ES cell
LEFTY1 (LEFTB)
NM_020997.2
Undifferentiated ES cell
IFITM1
NM_003641.3
Undifferentiated ES cell
NODAL
Undifferentiated ES cell
UTF1
Undifferentiated ES cell
LEFTY2 (EBAF)
NM_003240.2
Undifferentiated ES cell
GRB7
NM_005310.2
Size
Applications
144 bp
Endo OCT3/4 RT-PCR
151 bp
Endo SOX2 RT-PCR
391 bp
NANOG RT-PCR
631 bp
GDF3 RT-PCR
306 bp
REX1 RT-PCR
371 bp
FGF4 RT-PCR
243 bp
ESG1/DPPA5 RT-PCR
408 bp
DPPA4 RT-PCR
608 bp
DPPA2 RT-PCR
446 bp
hTERT RT-PCR
397 bp
Endo KLF4 RT-PCR
328 bp
Endo c-MYC RT-PCR
242 bp
DNMT3B RT-PCR
277 bp
GABRB3 RT-PCR
237 bp
TDGF1 RT-PCR
188 bp
GAL RT-PCR
255 bp
LEFTB RT-PCR
229 bp
IFITM1 RT-PCR
234 bp
NODAL RT-PCR
171 bp
UTF1 RT-PCR
274 bp
EBAF RT-PCR
241 bp
GRB7 RT-PCR
hOCT3/4-AS1283:CTTCCCTCCAACCAGTTGCCCCAAAC hSOX2-S1430:GGGAAATGGGAGGGGTGCAAAAGAGG hSOX2-AS1555:TTGCGTGAGTGTGGATGGGATTGGTG NM_024865.2
ECAT4-macaca-968S:CAGCCC CGATTCTTCCACCAGTCCC ECAT4-macaca-1334AS: CGGAAGATTCCCAGTCGGGTTCACC
NM_020634.1
hGDF3-S243:CTTATGCTACGTAAAGGAGCTGGG hGDF3-AS850:GTGCCAACCCAGGTCCCGGAAGTT hREX1-RT-U:CAGATCCTAAACAGCTCGCAGAAT hREX1-RT-L:GCGTACGCAAATTAAAGTCCAGA hFGF4-RT-U:CTACAACGCCTACGAGTCCTACA hFGF4-RT-L:GTTGCACCAGAAAAGTCAGAGTTG
hpH34-AS259:ACTCAGCCATGGACTGGAGCATCC
hECAT15-1-AS916:TTTTTCCTGATATTCTATTCCCAT NM_138815.2
hECAT15-2-S85:CCGTCCCCGCAATCTCCTTCCATC hECAT15-2-AS667:ATGATGCCAACATGGCTCCCGGTG
NM_198253.2
hTERT-S3234:CCTGCTCAAGCTGACTCGACACCGTG hTERT-AS3713:GGAAAAGCTGGCCCTGGGGTGGAGC
NM_004235.4
hKLF4-AS1826:TGATTGTAGTGCTTTCTGGCTGGGCTCC hKLF4-S1128:ACGATCGTGGCCCCGGAAAAGGACC
NM_002467.3
hMYC-S253:GCGTCCTGGGAAGGGAGATCCGGAGC hMYC-AS555:TTGAGGGGCATCGTCGCGGGAGGCTG
NM_006892.3
hDNMT3B-S2502:TGCTGCTCACAGGGCCCGATACTTC hDNMT3B-S2716:TCCTTTCGAGC hDNMT3B-S2716:TCCTTTCGAGCTCAGTGCAC TCAGTGCACCACAAAAC CACAAAAC
NM_021912.3
hGABRB3-S1029:CCTTGCCCAAAATCCCCTATGTCAAAGC hGABRB3-AS1280:GTATCGCCAATGCCGCCTGAGACCTC
NM_003212.2
hTDGF1-S490:CTGCTGCCTGAATGGGGGAACCTGC hTDGF1-AS700:GCCACGAGGTGCTCATCCATCACAAGG
NM_015973.3
hGAL-S415:TGCGGCCCGAAGATGACATGAAACC hGAL-AS579:CCCAGGAGGCTCTCAGGACCGCTC hLEFTB-S794:CTTGGGGACTATGGAGCTCAGGGCGAC hLEFTB-AS1023:CATGGGCAGCGAGTCAGTCTCCGAGG hIFITM1-S166:CCCCAAAGCCAGAAGATGCACAAGGAG hIFITM1-AS368:CGTCGCCAACCATCTTCCTGTCCCTAG
NM_018055.4
hNODAL-S693:GGGCAAGAGGCACCGTCGACATCA hNODAL-AS900:GGGACTCGGTGGGGCTGGTAACGTTTC
NM_003577.2
hUTF1-S832:CCGTCGCTGAACACCGCCCTGCTG hUTF1-AS979:CGCGCTGCCCAGAATGAAGCCCAC hEBAF-S782:GCTGGAGCTGCACACCCTGGACCTCAG hEBAF-AS1032:GGGCAGCGAGGCAGTCTCCGAGGC hGRB7-S1250:CGCCTCTTCAAGTACGGGGTGCAGCTGT hGRB7-AS1467:TGGGCAGGCTGAGGCGGTGGTTTG
Allele Biotech-Introducing Cost Effectiveness to Research
Table 2 | Human iPS RT-PCR Primers Undifferentiated
PODXL
NM_005397.3
ES cell Undifferentiated
CD9
NM_001769.2
hCD9-S369:GTGCATGCTGGGACTGTTCTTCGGCTTC
BXDC2
NM_018321.3
hBRIX-S596:CACCACGGTATCATCCCAAAAGCCAACC hBRIX-
220 bp
CD9 RT-PCR
230 bp
BRIX RT-PCR
307 bp
MSX1
AS798:ACGCCGATGCATGTTTGGTGACTGGTAG MSX1
NM_002448.3
hMSX1-S665:CGAGAGGACCCCGTGGATGCAGAG hMSX1-AS938:GGCGGCCATCTTCAGCTTCTCCAG
Mesoderm
PODXL RT-PCR
hCD9-AS564:CACGCCCCCAGCCAAACCACAGCAG
ES cell Mesoderm
226 bp
hPODXL-AS1403:CCGGGTTGAAGGTGGCTTTGACTGCTC
ES cell Undifferentiated
hPODXL-S1204:TCCAGCCCCACAGCAGCATCAACTACC
T, brachyury
NM_003181.2
homolog
hBRACHYURY-S1292:GCCCTCTCCCTCCCCTCCACGCACAG
RT-PCR 274 bp
hBRACHYURY-AS1540:CGGCGCCGTTGCTCACAGACCACAGG
BRACHYURY/T RT-PCR
(mouse) Ectoderm
PAX6
NM_001604.4
hPAX6-S1206:ACCCATTATCCAGATGTGTTTGCCCGAG
317 bp
hPAX6-AS1497:ATGGTGAAGCTGGGCATAGGCGGCAG Endoderm
FOXA2
NM_153675.2
hFOXA2-S208:TGGGAGCGGTGAAGATGGAAGGGCAC
RT-PCR 216 bp
hFOXA2-AS398:TCATGCCAGCGCCCACGTACGACGAC Endoderm
SOX17
NM_022454.3
hSOX17-S423:CGCTTTCATGGTGTGGGCTAAGGACG
AFP
NM_001134.1
hAFP-S948:GAATGCTGCAAACTGACCACGCTGGAAC
608 bp
KRT8(CK8)
NM_002273.3
hCK8-S734:CCTGGAAGGGCTGACCGACGAGATCAA hCK8-AS9
SOX17 RT-PCR
281 bp
hAFP-AS1201:TGGCATTCAAGAGGGTTTTCAGTCTGGA Endoderm
FOXA2 RT-PCR
hSOX17-AS583:TAGTTGGGGTGGTCCTGCATGTGCTG Endoderm
PAX6
AFP RT-PCR
247 bp
CK8 RT-PCR
233 bp
CK18 RT-PCR
212 bp
MAP2
56:CTTCCCAGCCAGGCTCTGCAGCTCC Endoderm
KRT18
NM_199187.1
(CK18) Ectoderm
MAP2
Neuron Marker Dopaminergic
GFAP
hCK18-S1125:AGCTCAACGGGATCCTGCTGCACCTTG hCK18AS1322:CACTATCCGGCGGGTGGTGGTCTTTTG
NM_00103953
hMAP2-S5401:CAGGTGGCGGACGTGTGAAAATTGAGAGTG
8.1
hMAP2-AS5587:CACGCTGGATCTGCCTGGGGACTGTG
NM_002055.3
hGFAP-S1040:GGCCCGCCACTTGCAGGAGTACCAGG hGFAP-
Neuron Markers
RT-PCR 328 bp
GFAP RT-PCR
242 bp
AADC RT-PCR
256 bp
ChAT RT-PCR
298 bp
SLC6A3/DAT
AS1342:CTTCTGCTCGGGCCCCTCATGAGACG
Dopaminergic
DDC
NM_00108297 hAADC-S1378:CGCCAGGATCCCCGCTTTGAAATCTG hAADC-
Neuron Markers
(AADC)
1.1
AS1594:TCGGCCGCCAGCTCTTTGATGTGTTC
Dopaminergic
CHAT
NM_020984.3
hChAT-S1360:GGAGGCGTGGAGCTCAGCGACACC hChAT-AS1
Neuron Markers
592:CGGGGAGCTCGCTGACGGAGTCTG
Dopaminergic
SLC6A3/
Neuron Markers
DAT DAT
Dopaminergic
LMX1B
NM_001044.3
hDAT-S1935:ACAGAGGGGAGGTGCGCCAGTTCACG hDAT-AS2 207:ACGGGGTGGACCTCGCTGCACAGATC
NM_002316.2
Neuron Markers
hLMX1B-S770:GGCACCAGCAGCAGCAGGAGCAGCAG
RT-PCR 276 bp
hLMX1B-AS1020:CCACGTCTGAGGAGCCGAGGAAGCAG
Cardiomyocyte
MYL7
NM_021223.2
hMYL2A-S258GGGCCCCATCAACTTCACCGTCTTCC hMYL2A-
Markers
(MYL2A)
Cardiomyocyte
TNNT2
NM_00100143
hTnTc-S524:ATGAGCGGGAGAAGGAGCGGCAGAAC hTnTc-
Markers
(TnTc)
2.1
AS730:TCAATGGCCAGCACCTTCCTCCTCTC
Cardiomyocyte
MEF2C
NM_002397.3
hMEF2C-S1407:TTTAACACCGCCAGCGCTCTTCACCTTG
PCR 236 bp
AS468TGTAGTCGATGTTCCCCGCCAGGTCC
Markers Myosi
Markers
(MYHCB)
NM_000257.2
hMYHCB-S5582:CTGGAGGCCGAGCAGAAGCGCAACG
MYL2A RTPCR
238 bp
TnTc RT-PCR
239 bp
MEF2C RT-
hMEF2C-AS1618:TCGTGGCGCGTGTGTTGTGGGTATCTCG
Cardiomyocyte
LMX1B RT-
PCR 258 bp
hMYHCB-AS5815:GTCCGCCCGCTCCTCTGCCTCATCC
MYHCB RTPCR
X : Signies corrections/typos to Takahashi, K., et al., Induction of pluripotent stem cells from adult human broblastsby dened factors. Cell, 2007. 131(5): p. 861-72.
Allele Biotech-Introducing Cost Effectiveness to Research